A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine
Status:
Completed
Trial end date:
2003-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effectiveness of treatment with BMS-232632 to
that of efavirenz (EFV) when both are used with zidovudine (ZDV) and lamivudine (3TC).
Phase:
Phase 3
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Atazanavir Sulfate Efavirenz Lamivudine Lamivudine, zidovudine drug combination Zidovudine